# RAB22A

## Overview
RAB22A is a gene that encodes a member of the RAS oncogene family, specifically a small GTPase protein involved in intracellular vesicle trafficking. The RAB22A protein plays a crucial role in endosomal transport, influencing the sorting and recycling of membrane proteins, which is vital for maintaining cellular signaling and homeostasis (Guadagno2019Rab). Structurally, it shares the characteristic features of the Rab family of small GTPases, including a central β-sheet surrounded by α-helices and key domains for GTP binding and regulation (Yu2023Localization; Park2013Structural). Functionally, RAB22A is active in early endosomes and is essential for processes such as endocytosis and membrane dynamics, impacting cellular responses to external stimuli (Guadagno2019Rab). Its interactions with various proteins, including those involved in cancer progression, underscore its significance in both normal cellular processes and disease states (Shakya2018Rab22A; Zhong2021Rab22aNeoF1). Alterations in RAB22A expression have been linked to several cancers, highlighting its potential as a target for therapeutic interventions (Wen2023Characterization; Sun2018Regulation).

## Structure
The RAB22A protein, a member of the RAS oncogene family, exhibits a typical structure characteristic of the Rab family of small GTPases. Its primary structure consists of a sequence of 194 amino acids, as observed in both chicken and mouse homologs, with a high degree of conservation across species (Yu2023Localization). The secondary structure includes a central 6-stranded mixed β-sheet surrounded by 5 α-helices, a configuration first identified in the H-Ras protein (Park2013Structural). 

The tertiary structure of RAB22A features key domains such as the GTP-binding site and the Switch I and Switch II regions, which are crucial for its function and regulation (Yu2023Localization). These regions are involved in nucleotide binding and are essential for the protein's activity. The N/TKCD motif is also present, aiding in nucleotide discrimination (Park2013Structural).

Post-translational modifications, such as prenylation, are likely to occur, facilitating membrane attachment, although specific modifications for RAB22A are not detailed in the provided context. The protein does not appear to have a quaternary structure as no information on multimeric forms is available. Splice variant isoforms are not mentioned in the context provided.

## Function
RAB22A is a small GTPase that plays a significant role in intracellular vesicle trafficking, particularly in endosomal transport. It is involved in the sorting and recycling of membrane proteins, which is crucial for maintaining cellular signaling and homeostasis. RAB22A is active in early endosomes, where it contributes to processes such as endocytosis and membrane dynamics (Guadagno2019Rab). This activity is essential for the proper functioning of various cellular processes, including cell signaling, division, and migration. By regulating the transport of membranes and cargoes between different cellular compartments, RAB22A ensures the efficient functioning of eukaryotic cells (Guadagno2019Rab).

In healthy human cells, RAB22A's role in endosomal transport influences the trafficking of proteins and lipids, impacting cellular responses to external stimuli. This function is vital for the dynamic regulation of the cell surface and intracellular compartments, affecting processes such as nutrient uptake, receptor recycling, and signal transduction. The precise mechanisms by which RAB22A operates in these pathways are critical for understanding its broader implications in cell biology and organismal physiology (Guadagno2019Rab).

## Clinical Significance
Alterations in the expression of the RAB22A gene have been implicated in various cancers. In hepatocellular carcinoma (HCC), RAB22A is often upregulated, and its high expression is associated with poor prognosis, affecting overall survival, disease-specific survival, and progression-free intervals. This suggests that RAB22A plays a significant role in the progression and prognosis of HCC (Wen2023Characterization). In breast cancer, RAB22A is upregulated and linked to tumor production and lymph node metastasis. It is regulated by miR-193b, which downregulates RAB22A expression, thereby inhibiting breast cancer growth and metastasis (Sun2018Regulation).

In colorectal cancer, RAB22A is part of a regulatory axis involving the long non-coding RNA MCF2L-AS1 and miR-105-5p. This axis influences cancer cell proliferation, migration, and invasion, with RAB22A being a critical component in promoting malignancy (Kong2021LncRNA). In melanoma, RAB22A is significantly upregulated and correlates with advanced cancer stages, affecting cell proliferation, migration, and invasion (Yong2021Cancerdriving). These findings highlight the oncogenic potential of RAB22A across different cancer types, making it a potential target for therapeutic interventions.

## Interactions
RAB22A, a member of the RAS oncogene family, is involved in various protein interactions that are crucial for its role in intracellular vesicle trafficking. It interacts with the kinesin motor protein KIF13A, which is essential for the formation and stabilization of recycling endosomes (REs). This interaction is distinct from the Rab11-KIF13A interaction, as it involves the stalk domain of KIF13A (Shakya2018Rab22A). RAB22A also forms a complex with BLOC-1 and BLOC-2 complexes on endosomal membranes, which is vital for the biogenesis of REs. This complex is stabilized by RAB22A, and its depletion significantly reduces the membrane association of BLOC-1 and BLOC-2 (Shakya2018Rab22A).

In cancer contexts, RAB22A interacts with proteins involved in cancer progression. In osteosarcoma, the Rab22a-NeoF1 fusion protein interacts with PYK2, promoting lung metastasis through exosomal secretion. This interaction is crucial for M2 polarization and the formation of a pre-metastatic niche (Zhong2021Rab22aNeoF1). In breast cancer, RAB22A is associated with hypoxia-inducible factors, which mediate microvesicle formation and enhance cancer cell invasion (Wang2014Hypoxiainducible). These interactions highlight RAB22A's role in both normal cellular processes and disease progression.


## References


[1. (Yu2023Localization) Fengmei Yu, Muhammad Akmal Raheem, Yang Tan, Muhammad Ajwad Rahim, Lisha Zha, Jun Zhang, Zhiwei Zhu, Zhonghua Li, and Fangfang Chen. Localization of chicken rab22a in cells and its relationship to bf or ii molecules and genes. Animals, 13(3):387, January 2023. URL: http://dx.doi.org/10.3390/ani13030387, doi:10.3390/ani13030387. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ani13030387)

[2. (Shakya2018Rab22A) Saurabh Shakya, Prerna Sharma, Anshul Milap Bhatt, Riddhi Atul Jani, Cédric Delevoye, and Subba Rao Gangi Setty. Rab22a recruits <scp>bloc</scp> ‐1 and <scp>bloc</scp> ‐2 to promote the biogenesis of recycling endosomes. EMBO reports, November 2018. URL: http://dx.doi.org/10.15252/embr.201845918, doi:10.15252/embr.201845918. This article has 38 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.15252/embr.201845918)

[3. (Sun2018Regulation) Liang Sun, Miao He, Ning Xu, Da-Hai Xu, Yaacov Ben-David, Zhao-Ying Yang, and You-Jun Li. Regulation of rab22a by mir-193b inhibits breast cancer growth and metastasis mediated by exosomes. International Journal of Oncology, September 2018. URL: http://dx.doi.org/10.3892/ijo.2018.4571, doi:10.3892/ijo.2018.4571. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ijo.2018.4571)

[4. (Wang2014Hypoxiainducible) Ting Wang, Daniele M. Gilkes, Naoharu Takano, Lisha Xiang, Weibo Luo, Corey J. Bishop, Pallavi Chaturvedi, Jordan J. Green, and Gregg L. Semenza. Hypoxia-inducible factors and rab22a mediate formation of microvesicles that stimulate breast cancer invasion and metastasis. Proceedings of the National Academy of Sciences, June 2014. URL: http://dx.doi.org/10.1073/pnas.1410041111, doi:10.1073/pnas.1410041111. This article has 279 citations.](https://doi.org/10.1073/pnas.1410041111)

[5. (Guadagno2019Rab) Noemi Antonella Guadagno and Cinzia Progida. Rab gtpases: switching to human diseases. Cells, 8(8):909, August 2019. URL: http://dx.doi.org/10.3390/cells8080909, doi:10.3390/cells8080909. This article has 61 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells8080909)

[6. (Zhong2021Rab22aNeoF1) Li Zhong, Dan Liao, Jingjing Li, Wenqiang Liu, Jingxuan Wang, Cuiling Zeng, Xin Wang, Zhiliang Cao, Ruhua Zhang, Miao Li, Kuntai Jiang, Yi-Xin Zeng, Jianhua Sui, and Tiebang Kang. Rab22a-neof1 fusion protein promotes osteosarcoma lung metastasis through its secretion into exosomes. Signal Transduction and Targeted Therapy, February 2021. URL: http://dx.doi.org/10.1038/s41392-020-00414-1, doi:10.1038/s41392-020-00414-1. This article has 54 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41392-020-00414-1)

[7. (Kong2021LncRNA) Wencheng Kong, Hui Li, Lesi Xie, Guangxing Cui, Weigang Gu, Hongchen Zhang, Wencong Ma, and Yifeng Zhou. Lncrna mcf2l-as1 aggravates the malignant development of colorectal cancer via targeting mir-105-5p/rab22a axis. BMC Cancer, September 2021. URL: http://dx.doi.org/10.1186/s12885-021-08668-w, doi:10.1186/s12885-021-08668-w. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12885-021-08668-w)

[8. (Yong2021Cancerdriving) Cheryl Qian Ying Yong and Bor Luen Tang. Cancer-driving mutations and variants of components of the membrane trafficking core machinery. Life Sciences, 264:118662, January 2021. URL: http://dx.doi.org/10.1016/j.lfs.2020.118662, doi:10.1016/j.lfs.2020.118662. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.lfs.2020.118662)

[9. (Park2013Structural) Hyun Park. Structural basis of membrane trafficking by rab family small g protein. International Journal of Molecular Sciences, 14(5):8912–8923, April 2013. URL: http://dx.doi.org/10.3390/ijms14058912, doi:10.3390/ijms14058912. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms14058912)

[10. (Wen2023Characterization) Fukai Wen, Fanshuai Meng, Xuewen Li, Qingyu Li, Jiaming Liu, Rui Zhang, Yunzheng Zhao, Yu Zhang, Xin Wang, Shuai Ju, Yifeng Cui, and Zhaoyang Lu. Characterization of prognostic value and immunological roles of rab22a in hepatocellular carcinoma. Frontiers in Immunology, March 2023. URL: http://dx.doi.org/10.3389/fimmu.2023.1086342, doi:10.3389/fimmu.2023.1086342. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2023.1086342)